LOBB
Leipzig Obesity BioBank
The Leipzig Obesity BioBank (LOBB) was established in 2005 and aims to improve our understanding of the disease mechanisms of obesity and its accompanying diseases by collecting substances such as body fluids and tissue samples with associated data. The LOBB is supported by the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), the University of Leipzig and University of Leipzig Medical Center.
LOBB
Leipzig Obesity BioBank
The Leipzig Obesity BioBank (LOBB) was established in 2005 and aims to improve our understanding of the disease mechanisms of obesity and its accompanying diseases by collecting substances such as body fluids and tissue samples with associated data. The LOBB is supported by the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), the University of Leipzig and University of Leipzig Medical Center.
About the LOBB
What are the aims of the LOBB?
It is known that fat distribution plays a decisive role in the development of diabetes mellitus, lipometabolic disorders, cardiovascular diseases and some types of cancer. In particular, abdominal fat distribution (apple shape of the body) and the presence of fatty liver appear to be a high risk for the above-mentioned diseases.
The collected biomaterials and associated data are to be stored long-term and made available for research in order to improve the prevention, detection and treatment of these diseases. Biomedical correlations are to be determined through the long-term collection of many samples.
By linking medical information from tissue and body fluids, the LOBB aims to conduct basic research into obesity and associated diseases. The aim is to gain a more comprehensive understanding of obesity and its concomitant and secondary diseases and thus to develop targeted and better treatment methods.
Who can provide a sample?
The samples are provided by patients of Leipzig University Hospital and cooperating obesity centers in Germany as part of obesity treatment after detailed information and the consent of the participants.
What happens to the samples?
The collected biomaterials and data are processed, analyzed and stored proportionally. They are used for a wide range of medical research purposes for the benefit of the general public. The samples and coded data are used exclusively for research projects that have been approved by the Ethics Committee of Leipzig University.